...
首页> 外文期刊>Diagnostic pathology >Podocin and Beta Dystroglycan expression to study Podocyte-Podocyte and basement membrane matrix connections in adult protienuric states
【24h】

Podocin and Beta Dystroglycan expression to study Podocyte-Podocyte and basement membrane matrix connections in adult protienuric states

机译:Podocin和Beta Dystroglycan表达研究成人成年状态下足细胞-足细胞与基底膜基质的连接

获取原文
           

摘要

Background Podocytes can be the primary site of injury or secondarily involved in various protienuric states. Cross talk between adjacent foot processes and with basement membrane is important for slit diaphragm function. Does expression of podocyte associated proteins in kidney biopsies alter with site/type of primary injury? Genetic mutations of podocin result in steroid resistant FSGS. Can protein expression of podocin predict resistant cases to initiate further genetic evaluation? Methods Adult patients (n-88) with protienuria- minimal change disease(MCD)-22, focal segmental glomerulosclerosis(FSGS)-21,membranous glomerulonephritis(MGN)-25 and IgA nephropathy(IgAN)-20 were selected for immunohistochemistry with podocin and beta dystroglycan . Results were graded (0 - 3+scale )and compared with control biopsies and internal control. Treatment and follow up (6 months -2 ? years) of FSGS and MCD cases were collected. Results There was intense to moderate staining of the podocytes with podocin and β dystroglycan in the glomeruli in all cases (MCD, FSGS, IgAN and MGN) except for weak staining with β dystroglycan in 3 cases of MCD. There was loss of immunostains in areas of segmental/global sclerosis. There was no significant difference in the staining pattern between the groups. In primary podocytopathies, staining pattern did not differ between steroid resistant, sensitive or dependent cases. Conclusions Immunohistochemical expression of podocin and β dystroglycan does not differ in nephropathies which have different site of injury depending on absence (MCD and FSGS) or presence of immune deposits and their localization (MGN and IgAN). Podocin and β dystroglycan staining did not differentiate steroid sensitive and resistant cases, hence, does not give clue to initiate genetic studies. However, analysis of bigger cohort may be required. Summary Podocin and β dystroglycan immunohistochemistry was done to analyze podocyte - podocyte and podocyte -basement membrane matrix connections in adult protienuric states. Primary podocytopathies i.e. MCD and FSGS and secondary podocytopathy due to immune complex deposition i.e. MGN (subepithelial) and IgAN (mesangial) were analyzed. There was no difference in staining patterns between primary and secondary podocytopathies or between steroid sensitive, resistant and dependent cases of FSGS and MCD. Virtual slides The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/2258608781052786 webcite
机译:背景足细胞可能是损伤的主要部位,或继而参与各种蛋白质状态。相邻足部过程之间以及与基底膜之间的串扰对狭缝隔膜功能很重要。肾脏活检组织中足细胞相关蛋白的表达是否随原发性损伤的部位/类型而改变? Podocin的遗传突变导致抗类固醇的FSGS。 Podocin的蛋白表达能否预测耐药病例以启动进一步的基因评估?方法选择成年患者(n-88)患有非淋巴性微小改变疾病(MCD)-22,局灶性节段性肾小球硬化(FSGS)-21,膜性肾小球肾炎(MGN)-25和IgA肾病(IgAN)-20患者进行podocin免疫组化研究。和βdystroglycan。将结果分级(0-3+级),并与对照活检和内部对照进行比较。收集了FSGS和MCD病例的治疗和随访(6个月-2?年)。结果所有病例(MCD,FSGS,IgAN和MGN)的肾小球中足细胞均被足蛋白和βdystroglycan染色强烈至中度染色,除3例MCD中,βdystroglycan染色较弱。在节段性/整体性硬化症区域中免疫染色的丧失。两组之间的染色方式没有显着差异。在原代足细胞病中,类固醇耐药,敏感或依赖性病例的染色模式没有差异。结论Podocin和βdystroglycan的免疫组织化学表达在肾病中没有差异,这些肾病的损伤部位取决于缺失(MCD和FSGS)或免疫沉积物的存在及其定位(MGN和IgAN)。 Podocin和βdystroglycan染色不能区分类固醇敏感性和耐药性病例,因此不能为启动遗传研究提供线索。但是,可能需要分析更大的队列。总结进行了Podocin和βdystroglycan免疫组织化学分析了成年蛋白状态下足细胞-足细胞和足细胞-基底膜基质的连接。分析了原发性足细胞病变,即MCD和FSGS,以及由于免疫复合物沉积而引起的继发性足细胞病变,即MGN(膀胱上皮)和IgAN(系膜)。在原发性和继发性足细胞病之间或在类固醇敏感,耐药和依赖的FSGS和MCD病例之间,染色模式没有差异。虚拟幻灯片可以在这里找到本文的虚拟幻灯片:http://www.diagnosticpathology.diagnomx.eu/vs/2258608781052786

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号